MSMB and cancer: ,7,37 In this study, we expand upon these previous findings by demonstrating that higher levels of genetically predicted MSMB are associated with a 20% lower risk of overall prostate cancer in two independent European ancestry cancer GWAS, and confirm its protective role in both aggressive and early onset disease aetiology.